It has been reported that the chronic administration of FGF21 improved HDL cholesterol levels and reduced LDL cholesterol levels in rhesus monkeys and humans with diabetes and obesity [14, 15]. Here, FGF21 is linked to obesity due to melanocortin 4 receptor deficiency.